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Abstract: Neuronal axons and their growth cones recognize molecular guidance cues 
within the local environment, forming axonal pathways to produce precise neuronal 
networks during nervous system development. Chondroitin sulfates (CS), carbohydrate 
chains on chondroitin sulfate proteoglycans, exhibit great structural diversity and exert 
various influences on axons and growth cones as guidance cues or their modulators; 
however, the relationship between their structural diversity and function in axonal guidance 
is not well known. To uncover the roles of CS in axonal guidance, artificially modified 
hybrid molecules: CS derivatives of biotinylated CS and lipid-derivatized CS, were used. 
The experiments with biotinylated CS suggest that the growing axons act on their 
environment, modifying CS, and rendering it more favorable for their growth. The 
experiments with lipid-derivatized CS demonstrated that growth cones distinguish types of 
CS with different unit contents and are likely to discriminate the structural diversity of CS. 
The application of CS derivatives is useful in uncovering axon–environment interaction 
and structure–function relationship of CS directly. 
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1. Neuronal Circuit Formation 
During nervous system development, neurons extend axons through precise pathways, approach 
target regions, and find appropriate partner neurons or cells to form synapses. This process, known as 
neuronal circuit formation, is the structural basis of nervous system function. The tips of these axons, 
known as growth cones, sense subtle differences in the surrounding environment of cells or 
extracellular matrix, selecting a preferable pathway and avoiding unfavorable regions. Molecules 
influencing the behavior of growth cones are referred to as guidance cues. The molecules “attracting” 
and “repelling” the growth cones are classified into “attractive guidance cues” and “repulsive guidance 
cues,” respectively; these two groups were historically thought to be functionally distinct classes of 
molecules (Figure 1). In the past two decades, many of the guidance cues were identified, and this led 
to a better understanding of circuit formation. They were originally identified as different molecules 
with attractive or repulsive effects; however, the effect of a molecular guidance cue is not absolute but 
relative. Thus, depending on the presence of receptors or intracellular transduction machineries, 
growth cone attraction or repulsion behavior varies. A combination of guidance cues and regulation of 
growth cone sensitivity lead to a precisely ordered neuronal circuit as a whole [1]. 
Figure 1. Schematic drawing of axonal guidance. Neuronal growth cones sense their 
environment with surrounding cells or extracellular matrix, select their preferable pathway, 
and avoid unfavorable regions. Molecules influencing behaviors of the growth cones are 
referred to as guidance cues. The molecules encouraging axonal growth are called 
“attractive guidance cues” and promote axonal growth in a contact-mediated manner or 
attract growth cones in a diffusion-mediated manner. The molecules keeping away the 
growth cones are called “repulsive guidance cues” and inhibit growth in a contact-mediated 
manner or repulse growth cones in a diffusion-mediated manner. 
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2. Chondroitin Sulfate Proteoglycans in Neuronal Circuit Formation 
Natural covalently bound hybrid molecules of core protein and linear polysaccharide chains, 
glycosaminoglycans, are proteoglycans [2]. Depending on differences in the glycosaminoglycan 
chains, the molecules are classified into heparan sulfate proteoglycans (HSGP) with heparan sulfate 
(HS), chondroitin sulfate proteoglycans (CSPG) with chondroitin sulfate (CS), or keratan sulfate 
proteoglycans (KSPG) with keratan sulfate (KS). Each is involved in essential processes of nervous 
system development [3–6]. By interacting with various growth factors through their HS chains, HSPGs 
are involved in differentiation and circuit formation. It has been found that the glycosaminoglycan 
chains of CSPGs (CS) interact with other proteins such as growth factors to regulate their function 
indirectly; however, more recent findings indicate that CS is recognized directly through its receptors, 
exerting its effects as guidance cues [7–10]. Here, we review novel methods to examine CS  
structure-function relationship and its role in neuronal circuit formation.  
Considering the structural components of CSPG, it is understandable that the function of CSPG is 
derived from its core protein and/or CS chains. The core proteins, depending on their structure, 
participate in forming extracellular matrices through interactions with other extracellular matrix 
molecules. The CS chains consist of repeating disaccharide units of glucuronic acid (GlcA) and  
N-acetylgalactosamine (GalNAc), forming straight chains of 20–200 units, with sulfate groups at 
various positions on the sugar chains. In many cases, effects of CS inhibit axonal outgrowth [11–21]. 
For example, if the central nervous system is damaged in higher vertebrates, CS is accumulated in glial 
scar tissue, inhibiting axonal growth to prevent the axons from rewiring their pathway. Thus, CS is 
now becoming a major therapeutic target since animal experimental models of spinal cord injury 
showed that rewiring of the neuronal circuits is expected by clearance of pathologically accumulated 
CS [22–25]. In contrast, it has also been reported that CS exerts various effects on different neurons. 
For example, CS promotes neurites’ outgrowth of hippocampal neurons [26–29] and exerts trophic 
effects on rat retinal ganglion cells [30]. Recently, it was reported that CS is involved in ocular 
dominance plasticity in the primary visual cortex [31–34]. In sum, the literature suggests that CS, 
although one molecular entity, exerts diverse effects by interacting with various substances having 
different functional specificity. To understand axonal guidance and neuronal circuit formation, it is 
important to elucidate the mechanisms by which CS exerts a variety of functions.  
Sulfation at different positions of the backbone disaccharide units generates various units with 
different structures; the backbone disaccharide unit (GlcA-GalNAc) is designated as O-unit. 
Depending on the positions of the sulfate residues, the disaccharide units are designated as A-unit 
(GlcA-GalNAc4S), B-unit (IdoA-GalNAc4S, IdoA is C-5 epimer of GlcA), C-unit (GlcA-GalNAc6S), 
D-unit (GlcA2S-GalNAc6S), and E-unit (GlcA-GalNAc4S6S) (Figure 2). Various combinations of 
these units generate tremendous structural diversity, even in 1 CS chain, which carries information like 
“unit clustering” or “unit sequences.” Recent reports indicate that cells may recognize specific unit 
sequences of CS, which has led to investigations into the molecular mechanism of CS  
recognition [7,35–41].  
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Figure 2. Schematic representation of chondroitin sulfate (CS) units’ structures. CS is 
made up of unbranched polysaccharides composed of repeating units of disaccharide 
(glucuronic acid and N-acetylgalactosamine) that are classified into O-, A-, B-, C-, D-, and 
E-units depending on sulfation sites; the structural diversity of CS results from variable 
combinations of these units. (A)-unit of CS [GlcAβ1-3GalNAc(4-O-sulfate)]; (C)-unit of 
CS [GlcAβ1-3GalNAc(6-O-sulfate)]; (D)-unit of CS [GlcA(2-O-sulfate)β1-3GalNAc(6-O-
sulfate)]; (E)-unit of CS [GlcAβ1-3GalNAc(4,6-O-disulfate)]; (B)-unit of CS is an epimer 
of C5 position on GlcAs [IdoAα1-3GalNAc(4-O-sulfate)].  
 
3. Obstacles in Studying CS Function 
It has not necessarily been easy to investigate the relationship between the structure and function of 
CS. CS is biologically synthesized through multiple steps, for example, biosynthesis of (donor 
substrates of) individual monosaccharides, expression of saccharide carrier proteins, regulation of the 
carrier proteins’ expression, expression of enzymes involving CS chain elongation, activity regulation 
of the elongation enzymes, expression of CS sulfotransferases, and activity regulation of the 
sulfotransferases [42]. Considering the formation of CS chains through these multiple steps, it is clear 
that the structural diversity of CS such as “percentage contents of the units” “the clustering” or “the 
unit sequences” is not primarily encoded in genetic information. Until recently, it has been difficult to 
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generate chemically defined CS chains with a standard structure; generally one has been using CS 
chains purified from biological samples to investigate their function in the context of cellular 
environment. In the last few years, it is developed the synthetic method that positions sulfate groups at 
precise locations on the CS carbohydrate chain [43]. This figures out one of the methodological 
problems and makes it possible to investigate precisely structure-function relationship of CS. 
On the other hand, to study the function of CS, one still faces another methodological problem in 
investigating function of CS. CS in vivo covalently bound to its core protein, but CS samples 
commonly used are cut from the core proteins during the purification. Thus, to be precise, the effect of 
a CS chain without its core protein is not thought to be physiologically accurate. However, this has not 
been taken well into consideration, primarily due to the difficulty in assembling an appropriate 
experimental system.  
Because CSPG is a natural hybrid molecule, whose information is not primarily within its genome, 
it is difficult to prepare standardized CSPG or CS products in vitro as recombinant proteins. One needs 
to produce CS and core proteins and combine them to build up the hybrid molecule. Again, one has to 
maneuver the different structural diversity of CS on the same core protein. Thus, in investigating the 
structure–function relationship of CS, it is ideal that the disaccharide unit contents are shown in 
purified CSPG with a specific core protein from a biological sample, producing a catalogue library of 
the same core proteins carrying different kinds of structurally diverse CS, and comparing their effects. 
It is easy to imagine the difficulty in making such a library. 
These obstacles stem from, at least, two problems. The first problem is difficulty on obtaining CS 
with defined structure. The second is how to apply CS to cells physiologically as if it is on the core 
protein. To figure out the second problem, more physiological experiments are needed. In this review, 
we spotlight CS derivatives that were developed long ago [44,45] but have not been used enough and 
adequately in neuroscience. With using derivatives of CS, one is able to investigate effects of CS 
chains on proteins, which mimics CSPG artificially. One is also able to investigate CS on beads, which 
mimics dense distribution of CS localized in living tissue. To understand the function of CS in 
neuronal circuit formation, we introduce two kinds of CS derivatives. Both derivations here we review 
are on the reducing ends of the CS chains, leaving the non-reducing ends for cell interaction because 
CS chains are bound to their core protein at their reducing ends on native proteoglycans, which is to let 
the CS chains mimic the native features. Therefore, one expects that this effects the interaction of the 
glycans and cells like native CS chains on proteoglycans. Likewise, one expects that the free  
non-reducing ends of CS chains might affect cell behaviors differently like CS chains on the native 
proteoglycans. The CS derivatives open a way to investigate relationship between structural diversity 
of CS and its functional specificity. New ideas create novel values in the old techniques. 
4. Biotinylated Chondroitin Sulfate and Artificial Chondroitin Sulfate Proteoglycan 
The first derivative is “biotinylated chondroitin sulfate (CS-biotin)” [44], in which the reducing end 
of the CS purified from biological samples was chemically coupled with biotin (Figure 3). 
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Figure 3. Schematic drawings of biotinylated chondroitin sulfate (CS-biotin) (A) and the 
CS-biotin-streptavidin complex (B). The reducing end of CS is coupled with biotin and the 
CS-biotin-streptavidin complex is formed with high affinity between biotin and 
streptavidin; it is thought that the complex consists of a tetramer. (C) Complex of  
CS-biotin and streptavidin in non-denaturing polyacrylamide gel double-stained with 
SYPRO Ruby (1-3) or Alcian blue (1’-3’). Samples loaded are shown below each lane:  
1,1’ streptavidin; 2,2’ biotin-CS; 3,3’ mixed solution with CS-biotin and streptavidin. Open 
arrowheads: complex of CS-biotin and streptavidin; closed arrowhead: streptavidin; 
asterisk: unconjugated CS. (D) Streptavidin-biotin-CSD complex under the influence of 
retinal axons in vitro. (a–c) Retinal culture on streptavidin-biotin-CSD complex substrate, 
Staining: (a) MO-225, (b) axons, c merged image. Arrows indicate absence of MO-225 
staining under the axons, arrowheads indicate absence of MO-225 staining with no axons; 
the MO-225-negative areas are aligned like axon paths. (d–f) After mechanical removal of 
axons. Staining: (d) MO-225 staining; (e) anti-streptavidin staining; (f) merged image. 
Open arrowheads indicate the absence of MO-225 staining and presence of  
anti-streptavidin staining along the axon paths. Bars 20 µm. (C) and (D) are adapted from 
Ando et al. [46].  
 
 
CS is able to be biotinylated with the method of Sinohara et al. [44]. CS (50 nmol) solution in  
0.1 M MES buffer, pH 5.0 (100 µL), and EZ-Link biotin hydrazide (5 µmol, Pierce) solution in 
dimethylsulfoxide (100 µL) were mixed and incubated at 70 °C for 2 h, followed by the addition of 
sodium cyanoborohydrate (10 µmol), and further incubation at 70 °C for 16 h. The reaction mixture 
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was subjected to a PD-10 desalting column and then to a Superdex 30 HR 16/600 column using 0.2 M 
ammonium acetate as an eluent. The elution was monitored by UV absorbance at 225 nm, and the 
biotin-conjugated CS was obtained by freeze-drying 3 times.  
Ando et al. [46] generated complex of CS-biotin and streptavidin. The CS-biotin and streptavidin 
were mixed and electrophoresed on non-denaturing polyacrylamide gels. The protein portion of the 
complex was visualized fluorescently with SYPRO Ruby; subsequently, the carbohydrate portion of 
the complex was stained with Alcian blue in the same gels. A broad band stained with both SYPRO 
Ruby and Alcian blue was observed, indicating the formation of a complex between CS-biotin and 
streptavidin (Figure 3C). Unlike the sharp band for streptavidin, the band for the complex was broad in 
the higher molecular-weight range because of the variation in the molecular weights and anionic 
charges of the CS with varying lengths [46]. Because it is known that 1 biotin molecule binds to a 
streptavidin and streptavidin molecules form a tetramer, it is thought that the complex consists of a 
tetramer: 4 CS-biotins and 4 streptavidins [47]. Because the binding between biotin and streptavidin is 
known to be one of the highest affinities in the natural world, it is thought that the complex is stable in 
physiological conditions; thus, the complex is expected to be utilized in functional experiments as 
“artificial CSPG” with 4 CS chains on the core. Since it was confirmed that streptavidin itself in the 
complex (as the “core protein”) has no effect on axonal elongation, this made it possible to examine 
CS function in neuronal circuit formation. 
CS is inhibitory to axonal outgrowth of retinal ganglion cells. However, inspecting the distribution 
of CS around the pathway of retinal ganglion cells’ axons in vivo, the retinal axons are seen running on 
a region with densely distributed CS [48]. Indeed, a small but substantial population of retinal axons 
grows on a culture substrate containing CS. These results suggest that some, but not all, of the retinal 
axons are insensitive to the CS inhibitory effect. In the case of hippocampal neurons, it is reported that 
CS enhances neurite outgrowth [26–29]. These disparate findings indicate that the effects of CS differ 
between types of neurons, possibly because of varying sensitivity to CS. 
Ando et al. [46] used CS-biotin in investigating axonal elongation in vitro, which is a successful 
example of application of the CS derivative (Figure 3D); thus, here we describe their approach. They 
used CS-biotin to generate the CS-biotin-streptavidin complex as an artificial CSPG, and further 
examined the interaction between the retinal axons and CS. The culture substrate was prepared using 
the CS-biotin-streptavidin complex and was double-stained with anti-CS (MO-225) and  
anti-streptavidin. Both the antibodies showed uniform staining throughout the substrate when there is 
no axon, indicating an even distribution of the complex in the substrate. A small population of retinal 
axons grew on the substrate with CS-biotin-streptavidin. Along the axonal trajectories, small regions 
were observed with decreasing signal of anti-CS antibody immunostaining, but those same regions had 
a uniform signal of anti-streptavidin staining. These results indicate that the density of epitopes against 
the carbohydrate portion of the complex, CS, was reduced or absent. However, the epitopes against the 
protein portion, streptavidin, were present along the axonal trajectory. The uniform staining of  
anti-streptavidin polyclonal antibody indicated that the complex was distributed uniformly on the 
substrate, and that antibodies readily accessed the complex on the substrate with no mechanical 
hindrance by the axons; thus, the decreasing signal of anti-CS antibody staining is likely an effect of 
the axons on the complex. Since the signal for carbohydrate portion (anti-CS staining) was merely 
reduced, it seems that the retinal axons have a selective influence on the CS carbohydrate chain in their 
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local environment. It is a possibility that the retinal axons cut the carbohydrate chains of CS to reduce 
the length or modify the structure of CS, resulting in the observed epitope density reduction. However, 
further investigation is necessary to reveal its mechanism. Importantly, the reduction of the CS staining 
may have biological significance. For instance, axons may act upon their local environment to modify 
the carbohydrate chains of the CS and thus render the environment more suitable to their growth, 
which is thought to be an adaptation of the axons to their growth environment. 
It has never been reported that neurons cut or modify carbohydrate chains of CS in their 
extracellular environment, nor has there been any investigation for such a mechanism. However, since 
CS is one of the important players in preventing axons from rewiring in central nervous system injury, 
for example, in spinal cord injury, it is meaningful to point out all possible intrinsic mechanisms to 
modify the carbohydrate chains of CS in terms of therapeutic application. The derivative of CS-biotin 
constitutes an essential contribution to this field of study. 
As demonstrated above, the CS-biotin-streptavidin complex is useful in preparing artificial CSPG. 
Moreover, it can be used to prepare complexes of different types of CS chains on the same core 
protein. Since highly sulfated CS, for example D- or E-unit containing CS, is thought to be involved 
with neurite elongation or axonal guidance [7,28,29,36,39], it would be intriguing to use the complex 
with D- or E-unit containing CS in future investigations. The CS-biotin-streptavidin complex enables 
us to examine the relationship between the structural diversity of CS and its functional specificity. 
Application of the CS-biotin derivative may be expected not only in the investigation of neuronal 
circuit formation, but also in other fields.  
5. Lipid-Derivatized Chondroitin Sulfate and Polystyrene Beads Coated with Lipid-Derivatized 
Chondroitin Sulfate 
Experiments using neuronal culture are important because one is able to examine the effect of CS 
on neuronal cells directly. “The spot assay” in which CS is spotted on the culture substrate, has been 
commonly used up to this point. Comparing axonal trajectories inside and outside the CS spot, one 
expects to study the effects of CS on axons. However, there seems to be methodological difficulties 
with this approach. The CS spot on the substrate surface is subsequently coated with extracellular 
matrix-like laminin; however, the CS prevents laminin from being coated in the spot, resulting in a 
laminin density difference between the inside (lower density) and outside (higher density) of the spot 
(Ichijo, unpublished observation). On the other hand, to form a boundary of the spot, the coating order 
is essential; in the reverse order of coating, the spot is not created because of its hydrophilic surface. 
Since growth cones prefer a higher density of laminin, it is difficult to distinguish the effects of CS 
from the general effects of laminin. 
Additionally, “the neurite outgrowth assay” in which the CS is uniformly distributed on the culture 
substrate, the CS operates continuously on the whole neuronal cell body, making it difficult to analyze 
when and where the CS is causing an effect. Consequently, this technique might not be useful for 
examining CS effects on behaviors of neuronal growth cones. Thus, a two-dimensional substrate of CS 
is not necessarily suitable for investigating the effects of CS structural diversity on growth cones. 
Gilbert et al. (2005) pointed out this difficulty; to understand the functional roles of CS diversity, they 
covalently coupled CS to three-dimensional hydrogels [37].  
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To bypass the problems of the conventional assay and examine the effect of CS on axonal behavior 
directly, another derivative of CS is introduced. The amino group of phosphatidylethanolamine was 
chemically coupled on the reducing end of the CS chain to generate the “lipid-derivatized CS  
(CS-PE)”, which was originally developed by Sugiura et al. (Figure 4) [45].  
Figure 4. Schematic drawings of lipid-derivatized CS (CS-PE) (A) and CS-PE bead (B). 
The reducing end of the CS chain is coupled with an amino group of 
phosphatidylethanolamine to generate CS-PE (A). The CS-PE hydrophobically adheres on 
the surface of polystyrene beads, forming the CS-PE beads with CS chains arranged 
outwardly (B). Behavior of a retinal growth cone encountering a CS-PE bead is shown in a 
photomontage of time-lapse images (C). Typical behaviors of the retinal growth cones 
encountering CSE-PE beads are shown in (D) retraction and (E) turning away from  
the beads.  
 
 
CS (5.0 µmol) was oxidized with iodine (50 µmol) in 5 mL of methanol-water (1:10, v/v) at room 
temperature for 6 h. The oxidized CS was precipitated with 3 volumes of 95% (v/v) ethanol containing 
1.3% (w/v) potassium acetate. The precipitate was dissolved in water and passed through a Dowex  
50 × 8 (H+) resin. The solution was concentrated at 40 °C in vacuo, and the remaining water was 
replaced by the addition of dimethylformamide (DMF) followed by evaporation several times. The 
DMF solution (5 mL) was allowed to stand at 4 °C for 72 h, to which dipalmitoyl-phosphatidyl 
ethanolamine (PE, 250 µmol) in 0.5 mL of chloroform was added. The mixture was stirred at 60 °C for 
6 h, then concentrated in vacuo, and suspended with 0.5 mL of 0.2 M NaCl. The undissolved material 
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(excess PE) was removed by centrifugation. The supernatant was subjected to a TSK-gel Phenyl 5PW 
column using 0.2 M NaCl as a wash and 30% (v/v) methanol-water as an eluent. The PE-conjugated 
CS was obtained via concentration and freeze-drying.  
The CS-PE is amphipathic, consisting of a hydrophilic CS chain and a hydrophobic 
phosphatidylethanolamine. The PE portion of the CS-PE hydrophobically adheres on the surface of 
polystyrene beads, forming the CS-PE beads with CS chains arranged outwardly. Spreading the CS-PE 
beads on the culture dish, one is able to closely observe behaviors of axonal growth cones approaching 
and encountering the CS-PE beads in time-lapse movies. Moreover, by using each unit-enriched  
CS-PE (CSA-, CSC-, CSD-, or CSE-PE), one is able to prepare the CS-PE beads with various CS 
structural diversities (CSA-PE beads and so on).  
This method, the “CS-PE beads assay” enables Simbo et al. to compare effects of CS with different 
structural diversity on the behavior of retinal growth cones directly in time-lapse movies  
(Figure 4) [49]. Growth cones of the retinal ganglion cells avoided E-unit containing CS-PE beads 
(CSE-PE beads), exhibiting significant repulsion or turning away from the CSE-PE beads. The effects 
of CSE-PE on the retina growth cones were quenched by treatment of the beads with chondroitinase 
ABC. The beads with other types of CS (CSA-, CSC-, and CSD-PE) or the beads without CS had no 
significant effect. Therefore, the retinal growth cones differentiated the CS on the beads and 
selectively moved away from the E-unit-containing CS. Moreover, the repulsive effects of CSE-PE 
beads are different from the well-known proteinaceous repulsive guidance factors like ephrins or 
semaphorins [50,51], because CSE-PE beads induce various continuous degrees of moving away 
behaviors, much like volume control. Thus far, the mechanisms moderating the repulsive effects of 
CSE are not known; therefore, further investigation is needed. There are several possible hypotheses 
addressing the differential effects between heterogeneous CSE chains or differing sensitivity between 
retinal growth cones. Since CS consists of a linear carbohydrate chain with 20–200 disaccharide units, 
it is able to carry large amounts of information in the heterogeneous structure of CS, such as sequences 
of the units or clustering of the unit inside the chain, which might be suitable for fine regulation of 
axonal behaviors in contrast to the proteinaceous guidance factors. With polystyrene beads coated with 
lipid-derivatized CS, one is able to examine the structural diversity and functional specificity of CS. 
Lipid-derivatized CS is applicable not only in the investigation of axonal guidance but also other 
experimental approaches for biological phenomena. 
6. Further Problems in CS Research 
Here we have reviewed methodology using CS derivatives, CS-biotin and CS-PE, and their 
application in axonal guidance research. These methods have opened new possibilities although there 
is a limitation. There are still problems in CS research. The problem on how to elucidate structural 
diversity of CS is generally recognized, which might be also a bottleneck of applying the CS 
derivatives in neuroscience and biomedical sciences. One is not being able to determine the “sequence 
of the units in CS chain” practically. Until recently, there had been no useful method synthesizing 
particular CS chains. Therefore, one had to obtain biological samples of CS from many organisms, 
chemically analyze them with percentages of the unit contents, and classify them in terms of the 
dominant unit contents, into CSA, CSC, and so on. However, these CS samples are not regarded as CS 
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with defined structures. To overcome the problem, Gama et al. [43] developed the chemically 
synthetic method that positions sulfate groups at precise locations on the CS carbohydrate chain and 
obtained CS carbohydrate chains with the standard structure, such as tetrasaccharides of defined 
sulfation pattern with A-, C-, E-, and so on. Sugiura et al. [52] have also recently developed a novel 
method of synthesizing CS species chemo-enzymatically with defined lengths and defined sulfate 
compositions. These open the way to generate a CS library with defined structure.  
Investigating effects of defined CSs is a promising way to understand structure-function 
relationship of CS although it is not thought to be perfectly enough; one should consider effects of the 
defined CSs on their core protein. Combining CS-biotin or CS-PE with the defined CS structure would 
enable us to investigate the precise linkage between structure and function of CS in more physiological 
conditions. After completing this step of investigations, one is able to consider the problems of 
structural diversity and functional specificity of CS why the structure of CS is so diverse or what 
sequences of CS code.  
Recently, the function of CS has been successfully investigated by analysis of genetic network 
between extracellular factors and their receptors with using genetically modified mice; thus, these 
genetic approaches seem promising in overcoming the obstacles in CS function research [7–10]. In 
fact, the existence of receptors specific to CS carbohydrate chains has been proposed. In contrast, 
methods using CS derivatives are thought to directly access the effect of CS on neurons, which is 
complementary to the genetic approaches. Our understandings of CS function and its structural 
diversity are expected to be promoted by the combined use of these direct in vitro and indirect  
genetic approaches. 
Novel ideas regarding other CS derivatives should lead to further breakthroughs and progress in this 
field of research. In addition to the derivatives described here, there appear to be other promising 
derivatives; for example, fluorescently labeled CS derivatives [53]. By combining both existing and 
new ideas for the use of CS derivatives with genetic approaches, the linkage between the structure and 
function of CS can be elucidated. 
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